日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of peripheral artery disease (PAD) on risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes

外周动脉疾病(PAD)对2型糖尿病患者发生主要不良心血管事件(MACE)风险的影响

Amamoo, James; Xie, Lin; Steffens, Andrea; Buysman, Erin; Swift, Caroline; Mehanna, Sherif; Gronroos, Noelle N; Bonaca, Marc P

Monthly Headaches and Severity in Patients on Galcanezumab or Traditional Preventive Migraine Medication: A 24-Month Claims and Electronic Health Records Study

接受 Galcanezumab 或传统预防性偏头痛药物治疗的患者每月头痛次数和严重程度:一项为期 24 个月的索赔和电子健康记录研究

Varnado, Oralee J; Vu, Michelle; Kim, Gilwan; Hoyt, Margaret; Buysman, Erin; Nayyar, Abhinav; Anand, Shikha; Viktrup, Lars

Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL

在慢性阻塞性肺疾病(COPD)且血液嗜酸性粒细胞计数≤300个/μL的患者中,噻托溴铵/奥洛达特罗或糠酸氟替卡松/乌美溴铵/维兰特罗的临床疗效相当。

Sethi, Sanjay; Clark, Brendan; Buysman, Erin K; Sargent, Andrew; Bengtson, Lindsay G S

Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims Study

美国回顾性索赔研究:接受 Galcanezumab 治疗的成年患者与接受标准预防性药物治疗的成年患者在 24 个月内的治疗模式和医疗资源利用情况(按性别和偏头痛发作频率划分)

Varnado, Oralee J; Vu, Michelle; Buysman, Erin K; Kim, Gilwan; Allenback, Gayle; Hoyt, Margaret; Trenz, Helen; Cao, Feng; Viktrup, Lars

Glycemic and Cost Outcomes among Hispanic/Latino People with Type 2 Diabetes in the USA Initiating Dulaglutide versus Basal Insulin: a Real-World Study

美国2型糖尿病西班牙裔/拉丁裔患者使用度拉糖肽与基础胰岛素治疗的血糖控制和成本结果:一项真实世界研究

Hoog, Meredith; Maldonado, Juan M; Wangia-Dixon, Ruth; Halpern, Rachel; Buysman, Erin; Gremel, Garrett W; Huang, Ahong; Konig, Manige

Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide

接受口服索玛鲁肽治疗的2型糖尿病患者的真实世界治疗模式

Swift, Caroline; Frazer, Monica S; Gronroos, Noelle N; Sargent, Andrew; Leszko, Michael; Buysman, Erin; Alvarez, Sara; Dunn, Tyler J; Noone, Josh; Guevarra, Mico

Real-world HbA(1c) changes and prescription characteristics among type 2 diabetes mellitus patients initiating treatment with once weekly semaglutide for diabetes

真实世界中接受每周一次司美格鲁肽治疗的 2 型糖尿病患者的糖化血红蛋白 (HbA1c) 变化和处方特征

Frazer, Monica; Swift, Caroline; Sargent, Andrew; Leszko, Michael; Buysman, Erin; Gronroos, Noelle N; Alvarez, Sara; Dunn, Tyler J; Noone, Josh; Gamble, Cory L

Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United States

在美国,开始使用加尔卡奈珠单抗或标准预防性偏头痛治疗后 24 个月内医疗资源利用情况和直接成本

Varnado, Oralee J; Vu, Michelle; Buysman, Erin; Kim, Gilwan; Allenback, Gayle; Hoyt, Margaret; Trenz, Helen; Cao, Feng; Viktrup, Lars

Real-World Hemoglobin A1c Changes, Prescribing Provider Types, and Medication Dose Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide

真实世界中接受口服索玛鲁肽治疗的2型糖尿病患者的糖化血红蛋白A1c变化、处方医生类型和药物剂量

Frazer, Monica; Swift, Caroline; Gronroos, Noelle N; Sargent, Andrew; Leszko, Michael; Buysman, Erin; Alvarez, Sara; Dunn, Tyler J; Noone, Josh; Guevarra, Mico

Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study

在美国真实世界环境中,老年 2 型糖尿病患者接受度拉糖肽治疗与基础胰岛素治疗的血糖控制和经济效益比较:DISPEL-Advance 研究

Hoog, Meredith; Paczkowski, Rosirene; Huang, Ahong; Halpern, Rachel; Buysman, Erin; Stackland, Sydnie; Zhang, Yiran; Wangia-Dixon, Ruth